Latest filing published 06 Mar 2026 for Rhythm Pharmaceuticals, INC., €23k.
Insider track record
Christopher Paul German: trading record in brief
This profile gathers the share dealings of Christopher Paul German in Rhythm Pharmaceuticals, Inc. Over a trading history stretching from 20 March 2024 to 4 March 2026, the count stands at 21 filings.
No open-market purchase appears, only 8 sales worth €1.0M. The rest of the record consists of 2 share grants and 11 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 6 March 2026 with an open-market sale (€433k) in Rhythm Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Paul German
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$17.9727.0% of flowCommon StockSEC:0001104659-26-024750:0
- 1,162 sharesCommon StockSEC:0001104659-26-023018:0
- 3,613 sharesCommon StockSEC:0001104659-26-009766:0
- 1,000 shares@ US$17.9717.9% of flowCommon StockSEC:0001104659-25-078814:0
- 2,000 shares@ US$17.9735.6% of flowCommon StockSEC:0001104659-25-067428:0
- 1,069 shares@ US$17.9719.5% of flowCommon StockSEC:0001104659-25-058954:0
- 1,163 sharesCommon StockSEC:0001104659-25-027336:0
- 1,807 sharesCommon StockSEC:0001104659-25-015319:0
- 1,163 sharesCommon StockSEC:0001104659-24-043249:0
9 of 9 declarations
